J&J reports positive topline outcomes from Phase III NSCLC combo therapy trial
The Phase III MARIPOSA trial involved 1,074 subjects.
08 January 2025
08 January 2025
The Phase III MARIPOSA trial involved 1,074 subjects.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.